LILIANA SAMPAIO COSTA MENDES

Dr. LILIANA SAMPAIO COSTA MENDES

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
SRSara Cardoso Paes Rose
Sara Cardoso Paes Rose
DCDébora Vilela Cunha
Débora Vilela Cunha
SCSandra Cobra
Sandra Cobra
JTJosé Eduardo Trevizoli
José Eduardo Trevizoli
MCMarcos de Vasconcelos Carneiro
Marcos de Vasconcelos Carneiro
LMLILIANA SAMPAIO COSTA MENDES
LILIANA SAMPAIO COSTA MENDES
SUMMARY Hepatopulmonary Syndrome (HPS) is a complication of cirrhosis that worsens the disease's prognosis, pre and post liver transplant. The objective of this study is to analyze the prevalence of HPS in cirrhotic patients at our service and to correlate it with oxygen saturation (SatO2) using a pulse oximeter to evaluate if this is useful as a screening test for HPS. A prospective study was conducted in patients with hepatic cirrhosis conventionally selected from 2014 to 2016. All the patients underwent an echocardiogram with microbubbles and oxygen saturation measurement by pulse oximetry. Those with intrapulmonary shunt were submitted to arterial blood gas analysis. The relationship between oxygen saturation and HPS was assessed by the multivariate model of binary logistic regression. We analyzed 77 patients, and 23.3% (18 patients) had all criteria for HPS. The relationship between HPS and SatO2 did not show statistical significance, even after the variables were adjusted for sex, age, and smoking. Oxygen saturation alone was not able to detect HPS in the sample of cirrhotic patients. More accurate methods for screening and diagnosis of the syndrome should be used.

27 February 2025 in Hepatology International
Verified
Journal Article
Closed access
PDF file
ÂMÂngelo Z. Mattos
Ângelo Z. Mattos
CDCaroline Machado Rotta Dornelles
Caroline Machado Rotta Dornelles
LSLeonardo de Lucca Schiavon
Leonardo de Lucca Schiavon
LMLILIANA SAMPAIO COSTA MENDES
LILIANA SAMPAIO COSTA MENDES
RFRoberto José de Carvalho Filho
Roberto José de Carvalho Filho
AGAlliance of Brazilian Centers for Cirrhosis Care – the ABC Group
Alliance of Brazilian Centers for Cirrhosis Care – the ABC Group

1 March 2022 in Arquivos de Gastroenterologia
Verified
Journal Article
Open access
MSMariana de Morais Lira Gouvea Siqueira
Mariana de Morais Lira Gouvea Siqueira
LCLuiz Augusto Casulari
Luiz Augusto Casulari
WFWladimir Magalhães de Freitas
Wladimir Magalhães de Freitas
MCMarcos de Vasconcelos Carneiro
Marcos de Vasconcelos Carneiro
LMLILIANA SAMPAIO COSTA MENDES
LILIANA SAMPAIO COSTA MENDES
Background Chronic hepatic disease is associated with osteoporosis, osteopenia or osteomalacia. Osteoporosis and fractures due to bone fragility present high prevalences and are more frequent in patients with liver cirrhosis than in the general population. The search for a diagnosis of osteopenia and osteoporosis in this population may allow early intervention and modify unfavorable outcomes. Objective To know the prevalence of osteopenia or osteoporosis and of fracture due to bone fragility in individuals with liver cirrhosis, the associated risk factors, and its compromise in their quality of life (QoL). Methods Observational, transversal study performed with 71 liver cirrhosis patients of the Hepatology Service of the Hospital de Base do Distrito Federal, Brasília, DF, Brazil, between July 2017 and December 2018. The patients were submitted to bone densitometry (DXA) of the lumbar spine and of the femoral neck, to x-ray of the lumbosacral spine and to the Chronic Liver Disease Questionnaire (CLDQ) for the evaluation of quality of life (QoL). The Fracture Risk Assessment (FRAX) major was calculated for patients >50 years old. The analyses were performed for the evaluation of the risk factors associated with lumbosacral spine fracture. Results The majority (62%) of the 71 evaluated patients was diagnosed with osteoporosis or osteopenia on DXA. Of the 44 patients with osteopenia or osteoporosis, 52.3% were female, with a mean age of 62.6±9.51 years old, with the majority (72.7%) being Child A, cirrhotics of alcoholic etiology (36.4%), and with an intermediate QoL according to the CLDQ (3.3). Regarding the patients with lumbosacral spine fracture, the mean age was 61.6±11.1 years old, 60% were female, most of them Child A (66.7%), of alcoholic etiology (46.7%), and with an intermediary QoL according to the CLDQ (3.5). The presence of osteopenia and/or osteoporosis was associated with lumbosacral fracture (P<0.001), without correlation with the other analyzed variables: age, body mass index, gender, presence and absence of ascites, Child-Pugh classification, vitamin D, calcium, and phosphorus serum concentration, cirrhosis etiology and FRAX major. Conclusion The prevalence of hepatic osteodystrophy was high, and the occurrence of lumbosacral spine fracture was more associated with osteoporosis and/or osteopenia among the cirrhotic patients studied. The QoL was intermediate and with no differences between cirrhotics with and without fracture.

19 August 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
Valeria Ferreira de Almeida e BorgesValeria Ferreira de Almeida e Borges
Valeria Ferreira de Almeida e Borges
HELMA PINCHEMEL COTRIMHELMA PINCHEMEL COTRIM
HELMA PINCHEMEL COTRIM
AAAntônio Ricardo C. F. Andrade
Antônio Ricardo C. F. Andrade
LMLILIANA SAMPAIO COSTA MENDES
LILIANA SAMPAIO COSTA MENDES
FPFrancisco Guilherme Cancela e Penna
Francisco Guilherme Cancela e Penna
LFLuiz Freitas
Luiz Freitas
Cholangiopathy has been described in survivors of severe COVID-19, presenting significant clinical parallels to the pre-pandemic condition of secondary sclerosing cholangitis in critically ill patients (SSC-CIP). We aimed to examine the liver histopathology of individuals with persistent cholestasis after severe COVID-19. Methods: We subjected post-COVID-19 cholestasis liver samples to routine staining techniques and cytokeratin 7 immunostaining and semi-quantitatively analyzed the portal and parenchymal changes. Results: All ten patients, five men, had a median age of 56, an interquartile range (IQR) of 51–60, and required intensive care unit and mechanical ventilation. The median and IQR liver enzyme concentrations proximal to biopsy were in IU/L: ALP 645 (390–1256); GGT 925 (664–2169); ALT 100 (86–113); AST 87 (68–106); and bilirubin 4 (1–9) mg/dL. Imaging revealed intrahepatic bile duct anomalies and biliary casts. We performed biopsies at a median of 203 (150–249) days after molecular confirmation of infection. We found portal and periportal fibrosis, moderate-to-severe ductular proliferation, and bile duct dystrophy in all patients, while we observed hepatocyte biliary metaplasia in all tested cases. We observed mild-to-severe parenchymal cholestasis and bile plugs in nine and six cases. We also observed mild swelling of the arteriolar endothelial cells in five patients. We observed a thrombus in a small portal vein branch and mild periductal fibrosis in one case each. One patient developed multiple small biliary infarctions. We did not observe ductopenia in any patient. Conclusions: The alterations were like those observed in SSC-CIP; however, pronounced swelling of endothelial cells, necrosis of the vessel walls, and thrombosis in small vessels were notable.

4 December 2021 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
AAAnna Paula Mendanha da Silva Aureliano
Anna Paula Mendanha da Silva Aureliano
RSRicardo Felipe Silva Soares
Ricardo Felipe Silva Soares
AFAlberto Queiroz de Farias
Alberto Queiroz de Farias
FSFelipe Nogueira Affiune Silva
Felipe Nogueira Affiune Silva
MCMarcos de Vasconcelos Carneiro
Marcos de Vasconcelos Carneiro
LMLILIANA SAMPAIO COSTA MENDES
LILIANA SAMPAIO COSTA MENDES
Pacientes com cirrose hepática podem evoluir para quadros de descompensação, refletindo em altas taxas de mortalidade. Escores preditores de prognóstico e mortalidade são ferramentas uteis no manejo do paciente com doença hepática crônica. O presente estudo investigou o potencial de escores e modelos preditores de mortalidade após o primeiro ano de internação em pacientes cirróticos atendidos em um hospital terciário do Distrito Federal, Brasil. Este é um estudo de coorte prospectiva que incluiu indivíduos adultos portadores de cirrose hepática, admitidos por descompensação aguda da cirrose, entre novembro de 2018 e maio de 2021. Os critérios para o término da prospecção foi um dos seguintes desfechos: fim do período supracitado, óbito ou transplante. Foram considerados para este estudo pacientes dos sexos masculino e feminino com cirrose admitidos no hospital por mais de um dia para tratamento da descompensação aguda, e inclusos após enquadramento nos critérios do estudo. As seguintes variáveis foram analisadas: sexo, faixa etária, etnia, causa base da cirrose, razão da admissão, presença de ascite, presença de encefalopatia, valores de exames em admissão (creatinina, sódio, bilirrubina total, INR, albumina) e gravidade de doença hepática pelos modelos de sistemas de escores CLIF-SOFA, MELD, MELD-Na e Child-Pugh, aferidos na admissão no intuito de prever mortalidade após um ano de seguimento. Dos 115 pacientes com cirrose hepática inicialmente inclusos, 63 foram excluídos do estudo por câncer ao longo do follow up, portanto, 52 completaram, sendo 65% do sexo masculino. Hepatite alcoólica foi a principal causa base da cirrose (46%), e sangramento intestinal principal causa de internação na descompensação (35%). Entre os parâmetros bioquímicos isolados, apenas albumina à admissão associou-se significativamente com o desfecho mortalidade em um ano. Entre os modelos avaliados, o CLIF-SOFA apresentou significativa capacidade como preditor relacionado a mortalidade neste período.

28 September 2020 in Acta gastroenterológica latinoamericana
Verified
Journal Article
Open access
LMLILIANA SAMPAIO COSTA MENDES
LILIANA SAMPAIO COSTA MENDES
BNBarbara Castro Neves
Barbara Castro Neves
AMAna Loisa Silva de Menezes
Ana Loisa Silva de Menezes
MCMarcos Vasconcelos Carneiro
Marcos Vasconcelos Carneiro
JTJose Eduardo Trevizoli
Jose Eduardo Trevizoli
WFWladimir Magalhães de Freitas
Wladimir Magalhães de Freitas
Introduction. Variable prevalence rates have been reported for Low bone mineral density (LBMD). Objectives. To determine the prevalence of LBMD in cirrhotic patients from a hospital outpatient clinic, to identify clinical and laboratory predictors of LBMD, and to determine the mean age at which LBMD was detected in this population. Methods. We conduced a cross-sectional study with 97 patients with liver cirrhosis for the presence of LBMD using bone densitometry of the lumbar spine and femoral neck. The prevalence of LBMD and mean age at detection of LBMD were evaluated. Correlation of LBMD with clinical-laboratory data was assessed, and uni and multivariate statistical analysis was performed. Results. The prevalence of LBMD was 50.5% in the 97 of the cases. LBMD was more frequent in participants over 50 years old (p = 0.001). There were no significant associations between the presence of LBMD and body mass index (p = 0.9), CHILD-PUGH score (p = 0.23), levels of 25-OH vitamin D (p = 0.5), parathyroid hormone (p = 0.5), calcium (p = 0.1), phosphorus (p = 0.3), and current or past smoking (p = 0.7). Age over 50 years remained a predictor of hepatic osteodystrophy even after adjusting for the other variables. Discussion. In conclusion LBMD was prevalent in the cirrhotic population studied. The age at LBMD diagnosis was between 15 and 20 years less than the osteoporosis screening age of the non-cirrhotic population. There were no clinical-laboratory factors that increased the suspicion of LBMD. Further studies are needed to determine whether these findings can be extrapolated to the cirrhotic population.